| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |